Barbara Weber

2022

In 2022, Barbara Weber earned a total compensation of $4.7M as President, Chief Executive Officer and Director at Tango Therapeutics, a 59% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$363,688
Option Awards$3,740,625
Salary$575,000
Other$2,474
Total$4,681,787

Weber received $3.7M in option awards, accounting for 80% of the total pay in 2022.

Weber also received $363.7K in non-equity incentive plan, $575K in salary and $2.5K in other compensation.

Rankings

In 2022, Barbara Weber's compensation ranked 695th out of 5,753 executives tracked by ExecPay. In other words, Weber earned more than 87.9% of executives.

ClassificationRankingPercentile
All
695
out of 5,753
88th
Division
Manufacturing
307
out of 3,133
90th
Major group
Chemicals And Allied Products
94
out of 1,419
93rd
Industry group
Drugs
81
out of 1,320
94th
Industry
Pharmaceutical Preparations
60
out of 966
94th
Source: SEC filing on April 24, 2023.

Weber's colleagues

We found two more compensation records of executives who worked with Barbara Weber at Tango Therapeutics in 2022.

2022

Alan Huang

Tango Therapeutics

Chief Scientific Officer

2022

Daniella Beckman

Tango Therapeutics

Chief Financial Officer

News

In-depth

You may also like